Position in ANIP
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$19,354,626
-$5,145,021 QoQ
Shares Held
233,808
-26.6% QoQ
Ownership
1.02%
of shares outstanding
% of Portfolio
4.22%
of 13F equity value
Holder Rank
#28
of 306 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANIP Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Jones Hill Capital LP holds $35,411,907 across 2 Drug Manufacturers - Specialty & Generic names. ANIP ranks #1 (54.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ANIP |
Ani Pharmaceuticals Inc
This page
|
233,808 | $19,354,626 | |
| 2 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
894,058 | $16,057,281 |
All Filings in ANIP
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,354,626 | 233,808 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $24,499,647 | 318,591 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||